Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy.
Maite AlvarezCarmen MolinaCarlos E De AndreaMyriam Fernandez-SendinMaria VillalbaJose Gonzalez-GomarizMaria Carmen OchoaAlvaro TeijeiraJavier Glez-VazFernando ArandaMiguel F SanmamedMaria E Rodriguez-RuizXinyi FanWen H ShenPedro BerraondoMarisol QuinteroIgnacio Melero BermejoPublished in: Journal for immunotherapy of cancer (2021)
Clinically feasible co-injections of BO-112 and a STING agonist attain synergistic efficacy able to eradicate distant untreated tumor lesions.